Clinical study for Xiangbin prescription for promoting recovery of gastrointestinal function after gynecological surgery

The Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Undergone gynecological laparoscopic surgery;
•2. Aged between 18 and 65 years old;
•3. Operation duration 0.5–4.5 h;
•4. Anesthesia duration 1.0–5.0 h;
•5. TCM syndrome Qi deficiency, Qi stagnation, blood stasis and bowel-qi?obstruction;
•6. Provided informed consent.

•1. Advanced malignant tumor cachexia or extreme weakness;
•2. Malignant tumors requiring extended radical surgery;
•3. Serious cardiovascular, liver, kidney, brain, lung co-morbidity and other combined diseases;
•4. Mental illness;
•5. Hypertension or diabetes poorly controlled by drugs;
•6. Allergic to the intervention;
•7. Pregnant or breast-feeding women;
•8. Severe malnutrition defined as serum albumin < 21g/L; pre-albumin < 0.10g/L;
•9. Hypertension or diabetes poorly controlled by drugs;
•10. Need for second abdominal surgery with severe intestinal adhesion;
•11. Serious complications occurring within 6 hours after surgery(e.g., multiple organ dysfunction);
•12. Postoperative intraperitoneal hyperthermic perfusion;
•13. Have undergone emergency surgery;
•14. Need for other gastroprokinetic drugs after surgery;
•15. Current participation in or past participation in other clinical trials within one month prior to this study;
•16. Considered inappropriate to participate in this study by the clinical investigators;
•17. Need for blood transfusion; blood loss during surgery > 400 mL.

发起方

The Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine